000830413 001__ 830413
000830413 005__ 20210129230513.0
000830413 0247_ $$2doi$$a10.1097/RLU.0000000000001672
000830413 0247_ $$2ISSN$$a0363-9762
000830413 0247_ $$2ISSN$$a1536-0229
000830413 0247_ $$2WOS$$aWOS:000402747200001
000830413 0247_ $$2altmetric$$aaltmetric:19998937
000830413 0247_ $$2pmid$$apmid:28481787
000830413 037__ $$aFZJ-2017-03962
000830413 082__ $$a610
000830413 1001_ $$0P:(DE-HGF)0$$aKirchner, Julian$$b0
000830413 245__ $$aEvaluation of Practical Interpretation Hurdles in 68Ga-PSMA PET/CT in 55 Patients
000830413 260__ $$aPhiladelphia, Pa.$$bLippincott Williams & Wilkins$$c2017
000830413 3367_ $$2DRIVER$$aarticle
000830413 3367_ $$2DataCite$$aOutput Types/Journal article
000830413 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1501249010_32060
000830413 3367_ $$2BibTeX$$aARTICLE
000830413 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000830413 3367_ $$00$$2EndNote$$aJournal Article
000830413 520__ $$aPurposeTo investigate the physiologic 68Ga-PSMA distribution and evaluate focal or diffuse radiotracer uptake in nonprostate cancer malignancies and in incidental findings.Methods68Ga-PSMA PET/CT scans in 55 men performed for prostate cancer (49) or renal cell carcinoma (6) staging were analyzed retrospectively. Two radiologists evaluated the datasets in 2 reading sessions. First, physiological 68Ga-PSMA uptake was evaluated. Second, scans were analyzed for incidental uptake. SUVmax and SUVmean were recorded. Other imaging modalities, histopathology, or clinical follow-up served as standard of reference.ResultsHomogenous 68Ga-PSMA uptake of the lacrimal glands (SUVmax, 15.7 ± 7.2), parotid glands (SUVmax, 24.4 ± 8.1), submandibular glands (SUVmax, 26.7 ± 7.1), vocal cords (SUVmax, 8.4 ± 3), Waldeyer ring (SUVmax, 10.4 ± 4.3), liver (SUVmax, 8.2 ± 2.5), spleen (SUVmax, 10.9 ± 3.9), kidneys (SUVmax, 66.4 ± 25.4), and pars descendens duodeni (SUVmax, 17.6 ± 8.9) was observed in all patients. In 65% and 36%, respectively, homogenous 68Ga-PSMA uptake of the colon descendens (SUVmax, 10.6 ± 9.2) and the rectum (SUVmax, 3.7 ± 1.1) was found. Approximately 22% exhibited a 68Ga-PSMA uptake of the thyroid (SUVmax, 4.5 ± 1.2), and 21% exhibited a 68Ga-PSMA uptake of the knee’s synovia (SUVmax, 2.9 ± 0.2). Furthermore, 68Ga-PSMA uptake was found in 1 patient because of fibrous dysplasia of the right os ilium (SUVmax, 7.7).ConclusionsPhysiologic distribution of 68Ga-PSMA comprises uptake in lacrimal and salivary glands, vocal cords, Waldeyer ring, liver, spleen, and kidneys as well as various parts of the intestine. Moreover, nonspecific tracer uptake is regularly found in the thyroid and the synovia of the knee. Incidental 68Ga-PSMA uptake can occasionally reveal nonprostate cancer–associated remodeling processes, such as fibrous dysplasia.
000830413 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000830413 588__ $$aDataset connected to CrossRef
000830413 7001_ $$0P:(DE-HGF)0$$aSchaarschmidt, Benedikt Michael$$b1$$eCorresponding author
000830413 7001_ $$0P:(DE-HGF)0$$aSawicki, Lino Morris$$b2
000830413 7001_ $$0P:(DE-HGF)0$$aHeusch, Philipp$$b3
000830413 7001_ $$0P:(DE-Juel1)132313$$aHautzel, Hubertus$$b4$$ufzj
000830413 7001_ $$0P:(DE-Juel1)131818$$aErmert, Johannes$$b5$$ufzj
000830413 7001_ $$0P:(DE-HGF)0$$aRabenalt, Robert$$b6
000830413 7001_ $$0P:(DE-HGF)0$$aAntoch, Gerald$$b7
000830413 7001_ $$0P:(DE-HGF)0$$aBuchbender, Christian$$b8
000830413 773__ $$0PERI:(DE-600)2045053-9$$a10.1097/RLU.0000000000001672$$gVol. 42, no. 7, p. e322 - e327$$n7$$pe322 - e327$$tClinical nuclear medicine$$v42$$x0363-9762$$y2017
000830413 909CO $$ooai:juser.fz-juelich.de:830413$$pVDB
000830413 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132313$$aForschungszentrum Jülich$$b4$$kFZJ
000830413 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131818$$aForschungszentrum Jülich$$b5$$kFZJ
000830413 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000830413 9141_ $$y2017
000830413 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz
000830413 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000830413 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000830413 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000830413 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN NUCL MED : 2015
000830413 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000830413 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000830413 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000830413 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000830413 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000830413 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000830413 920__ $$lyes
000830413 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000830413 980__ $$ajournal
000830413 980__ $$aVDB
000830413 980__ $$aI:(DE-Juel1)INM-5-20090406
000830413 980__ $$aUNRESTRICTED